Because an increased level of HERV-W RNA has been reported in brain tissue from MS patients [12], a precise technique that allows differentiating between MSRV and syncytin-1 (from ERVWE1 locus) mRNA would be very desirable. This evidence concerns the gene ERVW-1 and myeloid sarcoma.